Choice of Law • False Conflict • Pharmaceutical Product • Design-related Claims
P.D. v. Janssen Pharmaceuticals, Inc. et al, PICS Case No. 17-1390 (C.P. Philadelphia July 26, 2017) New, J. (14 pages).
Finding no “true conflict” between Pennsylvania law and North Carolina law as applied to plaintiff’s negligent design defect and strict liability design claims arising from his use of Risperdal®, the court applied Pennsylvania law under the state’s choice of law methodology and found the claims to be precluded. The court asked the appellate court to affirm its order granting the moving defendants summary judgment.
